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Intra- and interlaboratory variability of allergen-specific IgE levels in 
atopic dogs in three different laboratories using the Fc-ε receptor testing 
 
1. Introduction 
 
Atopic dermatitis (AD) is one of the most common canine skin diseases, affecting 3–15% of 
the population (Scott and Paradis, 1990; Scott et al., 2001; Hillier and Griffin, 2001; Reedy et 
al., 2002). It is defined as a genetically predisposed inflammatory and pruritic allergic skin 
disease with characteristic clinical features associated with IgE antibodies most commonly 
directed against environmental allergens (Halliwell, 2006). Canine AD is diagnosed by 
clinical criteria according to Willemse (1986) and Prelaud (1998), after exclusion of 
differential diagnoses of pruritus. Allergen-specific IgE concentrations are only one of many 
criteria for AD. Testing for allergen-specific IgE to identify environmental antigens which 
elicit an allergic response in the individual dog however is a precondition for allergen-specific 
immunotherapy (ASIT). ASIT is a commonly used and well-accepted therapy for humans and 
dogs with atopic diseases (James and Durham, 2008; Griffin and Hillier, 2001; Reedy et al., 
2002; Keppel et al., 2008). Several types of serologic tests have been developed and are 
widely used in veterinary practice, as they are easier to perform and not as time-consuming as 
intradermal allergy testing (IDT). These tests are based on the measurement of allergen-
specific IgE concentrations by ELISA using mono- or polyclonal antibodies or the Fc- ε 
receptor technique. The method evaluated in this study is the Fc-ε receptor test developed by 
Heska Corporation (Fort Collins, USA) and now available in various laboratories in Europe. 
These laboratories are ‘‘Allercept® Program Lab Partners’’, provided with defined test 
reagents and trained in the test procedure. Each laboratory can choose its specific panel of 
allergens. The test uses a recombinant a-chain of the human high affinity IgE receptor 
(FcεR1a) which has been shown to be highly specific for canine IgE antibodies (Wassom and 
Grieve, 1998; Stedman et al., 2001). In human medicine accredited laboratories perform tests 
to verify reproducibility and accuracy of measurements in different laboratories using 
identical methods. In veterinary medicine quality assurance programmes are implemented at 
the discretion of the laboratories. To the authors’ knowledge there are no studies that have 
investigated intra- and interlaboratory variability of the Fc- ε receptor test in different 
veterinary laboratories. The purpose of this study was to evaluate intralaboratory and 
interlaboratory variability of the Fc-ε receptor test in three laboratories. 
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 2. Material and methods 
 
2.1. Study population 
 
Fifteen atopic dogs of 14 different breeds with an age ranging from 1 to 11 years (mean age 
4.3 years) from 3 different dermatological services (Tiera¨ rztliche Spezialisten Hamburg, 
Dermatological Unit of Vetsuisse Faculty of Zurich, Dermatological service of Justus-Liebig-
University of Giessen) were included in the study. Diagnosis of ADwas based on compatible 
history and clinical criteria (Willemse, 1986; Prelaud, 1998). Other pruritic diseases, such as 
parasitic, bacterial or fungal diseases were excluded by appropriate diagnostic tests. Food 
adverse reaction was ruled out by failure to respond to an appropriate 8-week elimination diet. 
All dogs except one underwent IDT with 44–45 common allergens (Greer Laboratory, Lenoir, 
North Carolina) as a routine diagnostic procedure. Dogs were sedated with either 
medetomidine or xylazine, injection of allergens (Greer Laboratory, Lenoir, North Carolina) 
and interpretation of reactions were performed as described elsewhere (Reedy et al., 2002; 
Scott et al., 2001). Each dog was positive for at least one allergen. At the time of IDT, oral 
and topical glucocorticoids had to be withdrawn for 4 weeks, injectable glucocorticoids for 8 
weeks, antihistamines for 2 weeks and cyclosporin for at least 4 weeks. 
 
2.2. Serum samples 
 
At the same time as IDT was perfomed, blood was drawn by puncture of the cephalic or 
jugular vein and centrifuged immediately after collection. The serum from each dog was 
divided in six equal aliquots which were stored at _18 8C until being sent to the participating 
laboratories in the subsequent 4 weeks. Samples were sent from Monday to Wednesday, to 
avoid shipping over the weekend.  
 
2.3. Laboratories 
 
Three laboratories (LA, LB, LC) participated in the study, all using Allercept1, developed by 
Heska Corporation, USA. One laboratory (Heska Ag, Fribourg, Switzerland), was aware of 
the study protocol, the other laboratories were not. However, all analyses were blinded as 
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each specimen was labeled with a different dog and owner identity and batches from two to 
five dogs were sent in concurrently. 
 
2.4. Fc-e receptor test 
 
Serum concentrations of allergen-specific IgE antibodies were measured using the Fc-e 
receptor testing method as described elsewhere (Wassom and Grieve, 1998; Foster et al., 
2003). LA and LC measured allergen-specific IgE for 36 allergens and expressed the results 
as optic density (OD) units, with a range from 0 to >3000 OD. Values of 150 OD and above 
were considered positive. In LB 16 allergens were analysed. Results of LB were provided in 
reaction grades (RG) ranging from zero to five, depending on OD units in ELISA 
measurements (Table 1). Grade zero, identified as an optical density of less than 150, 
was regarded as a negative test result, grade 1–5 were interpreted as positive.  
Reaction Grade Optic Density Units 
0        ≤ 150 
1 151 – 250 
2 251 – 500 
3 501 – 1500 
4 1501 – 3000 
5 > 3000 
 
Table 1: Classification of Optic Density Units in Reaction Grades 
 
 
2.5. Statistical analysis 
 
For statistical analysis BMDP Statistical software 8.1 was used. For comparison between all 
three laboratories, OD units of LA and LC were translated into RG. Skewed data were 
3 
transformed logarithmically to achieve a log-normal distribution. Intra- and interlaboratory 
variabilities were calculated by three factorial analysis of variance (mixed model). 
p < 0.05 was considered significant. For interlaboratory correlation, Pearson’s (for parametric 
data of OD) or Spearman’s correlation (for non parametric data of RG) were used. A 
correlation coefficient r > 0.8 with a p value of <0.001 was considered indicative of a good 
correlation. 
 
2.6. Intralaboratory analysis 
 
Duplicate measurements were used to assess intralaboratory variability. For OD results of LA 
and LC geometric mean, geometric standard deviation and the individual dispersion factor for 
each allergen were calculated. The dispersion factor is calculated for logarithmic data 
analogous to the standard deviation in non-logarithmic data for assessment of variance. The 
higher the dispersion factor, the greater is the variance. The lowest possible value of the 
dispersion factor is 1, which means that there is no variance at all. The dispersion factor for 
the intralaboratory variability of the complete test was compared between LA and LC. The 
probability distribution function of the test was calculated. For LB only a descriptive analysis 
was possible due to abstracted results plotted in RG. Differences can only become obvious if 
data vary across class limits (see Table 1). Standard deviation (SD) and arithmetic mean 
were evaluated. Although possible, calculation of the coefficient of variance does not add 
more information on the intralaboratory variability, and was therefore not performed. 
Using the suggested cut-off point of 150 OD, results were classified as positive or negative. 
To assess intralaboratory differences regarding positive or negative results of the test, the 
percentage of differing measurements was calculated for each laboratory.  
 
2.7. Interlaboratory analysis 
 
Variability and correlation of OD results of each allergen was analysed comparing the 
duplicate measurements by three factorial analysis of variance (mixed model). Interlaboratory 
variability was assessed for RG of each allergen by evaluation of arithmetic mean and 
standard deviation. For interlaboratory correlation, Pearson rank correlation was used to 
compare LA/LB, LA/LC and LB/LC. To assess interlaboratory differences regarding positive 
or negative results of the test, the percentage of differing measurements was calculated. 
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3. Results 
 
Since data of OD units of LA and LC were positively skewed, they were transformed 
logarithmically. RG data were uniformly distributed, a logarithmic transformation was not 
necessary. LA and LC analysed allergen-specific IgE levels for 36 allergens in OD units and 
LB analysed 16 allergens in RG. Allergens which were measured only in one laboratory were 
excluded (Cryptomeria, rye, cedar). Altogether for LA and LC 35 allergens with 525 double 
measurements and for LB 15 allergens with 225 double measurements were included. 
 
3.1. Intralaboratory variability 
 
In Fig. 1 intralaboratory variability of LA and LC are depicted around 150 OD. The variation 
was calculated by the individual dispersion factor for each allergen. The cut-off point of 150 
OD was chosen to demonstrate the variability around this value, as in low absolute OD 
values, small changes account for a relatively great variability. In the two laboratories the 
dispersion factor of individual allergens and their range did not differ significantly. Those 
measured by LA ranged from 1.15 (Birch) to 6.63 (English plantain). Corresponding values 
in LC ranged from 1.19 (Dermatophagoides (D.)farinae) to 6.17 (Salsola kali). 
sOOO 
 
 
 
 
 
 
 
 
 
 
Figure 1: 
Intralaboratory variability of LA / LC 
Dispersion factor (LA = red lines, LC = black lines) shown for the cut off value of 150 OD 
(LA = yellow, LC = blue bars)   
 
Labor A & C
0
100
200
300
400
500
600
700
800
900
1000
1100
1200
D
. 
fa
ri
n
a
e D
.
A
c
a
ru
s
T
y
ro
p
h
a
g
u
s
L
e
p
id
o
g
ly
p
h
u
s
A
lt
e
rn
a
ri
a
C
la
d
o
s
p
o
ru
m
A
s
p
e
rg
ill
u
s
P
e
n
ic
ill
iu
m
M
ix
e
d
 g
ra
s
s
e
s
B
e
n
t 
g
ra
s
s
B
e
rm
u
d
a
J
o
h
n
s
o
n
 g
ra
s
s
S
o
rr
e
l
E
n
g
lis
h
M
u
g
w
o
rt
L
a
m
b
s
N
e
tt
le
R
a
g
w
e
e
d
P
a
ri
e
ta
ri
a
S
a
ls
o
la
 k
a
li
B
ir
c
h
A
ld
e
r
O
a
k
C
y
p
re
s
s
H
a
z
e
l
E
lm
B
e
e
c
h
P
o
p
la
r
M
a
p
le
W
ill
o
w
O
liv
e
F
le
a
 
C
a
t 
C
o
c
k
ro
a
c
h
Grenzwert A Grenzwert B
OD units 
5 
For assessment of the overall intralaboratory variability the dispersion factor of the complete 
test was evaluated. The dispersion factor for LA was 2.45 and for LC 2.19. Fig. 2 shows the 
probability distribution function. The function describes the range of possible values that a 
random variable can attain. It reflects the calculated probability to detect real positives by the 
test, depending on the measured value and the dispersion factor. The greatest variation in  
duplicate measurements was obtained in the range of OD values from 50 to 500. At 
an OD value of about 50, the probability to measure a false positive result was 10% and vice 
versa at an OD value of 500 the probability to get a false negative result was about 10%. 
 
 
 
Figure 2 Probability distribution function 
Probability for detection of real positives depending on measured value (calculation with log 
OD in normal distribution) regarding overall intralaboratory dispersion factor 
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Fig. 3 shows the intralaboratory variability of LB around the cut-off value of RG1, depicted as 
SD. SD ranges from 0 RG for eight allergens to 0.61 RG for D. farinae. In LA as well as in 
LC 17 of 525 measurements (3.24%) differed regarding positive or negative interpretation of 
allergy test results. LB reported differing results in 6 of 225 cases (2.66%). Overall disparity 
was 3.14% (40/1275 measurements). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 
Intralaboratory variability of LB  
Standard deviation (black lines) shown for the cut off value of RG 1  
 
3.2. Interlaboratory analysis 
 
Regarding interlaboratory variability, significant differences in OD units between LA and LC 
were detected for the mites Acarus siro, D. pteronyssinus and Lepidoglyphus destructor, the 
moulds Aspergillus fumigatus and Alternaria alternata, the trees willow and birch, the weed 
English plantain and cat epithelia (Table 2). There was a good correlation in 13 of 35 
allergens (Table 2). Significant differences in RG between the three laboratories were found 
for 4 of 15 allergens: nettle (p = 0.0021), mixed grasses (p = 0.0104), Alternaria alternata 
(p = 0.0159), and willow (p = 0.044) (Table 2). For analysis of correlation of RG, moulds had 
to be excluded since the majority of measurements showed RG 0 (data not shown). A good 
correlation between LA and LB was found for all allergens except D. pteronyssinus 
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(r = 0.62). Correlation between LA and LC was good except for nettle (r = 0.79). LB and LC 
correlated well, with the exception of D. pteronyssinus (r = 0.7), nettle (r = 0.71) and mixed 
grasses (r = 0.76) (Table 2). Interlaboratory differences in rating a result as positive or 
negative were evaluated separately for the 20 allergens measured only by LA and LC and for 
the 15 allergens measured by all three laboratories. Results differed 4 times (1.34%) in the 
300 measurements carried out by LA and LC alone. Of the remaining 225 measurements from 
all three laboratories, discrepancies were found in 21 (9.33%). LB differed twelve times from 
the other two, LC disagreed five times and LA four times. Overall disparity in 525 
measurements was 4.76% (25/525). 
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Laboratories LA / LC LA/LB/LC LA / LB LA / LC LB / LC 
Allergens Variability 
(OD 
values) 
Coefficient 
of 
correlation 
(OD 
values)   
Variability 
(RG)  
Coefficient 
of 
correlation 
(RG)  
Coefficient 
of 
correlation 
(RG)  
Coefficient 
of 
correlation 
(RG)  
Mites       
Dermatophagoides 
farina 
0.0883 0.987** 0.118 0.8882** 
 
0.9823** 
 
0.8937** 
 
Dermatophagoides 
ptyeronysinus 
0.0189* 0.747 0.1385 0.6173 
 
0.8779** 
 
0.7032 
 
Acarus siro 0.0034* 0.982** 0.7145 0.9067** 
 
0.8629** 
 
0.9186** 
 
Tyrophagus 
putrescentiae 
0.4285 0.921** 0.925 0.959** 
 
0.9332** 
 
0.9019** 
 
Lepidoglyphus 
destructor 
0.0044* 0.764 n.m. n.m. n.m. n.m. 
Moulds       
Alternaria alternata 0.0003* 0.429 0.0159* Excl. Excl. Excl. 
Cladosporium 
herbarum 
0.0564 0.095 0.3806 Excl. Excl. Excl. 
Aspergillus 
fumigates 
0.0426* -0.151 1 Excl. Excl. Excl. 
Penicillium 0.0974 0.497 0.3297 Excl. Excl. Excl. 
Grasses       
Mixed grasses 
(Gramineae 
mixtum) 
0.1743 0.93** 0.0104* 0.8675** 
 
0.9608** 
 
0.7564 
 
Bent grass 
(Argostis alba) 
0.1312 0.942** n.m. n.m. n.m. n.m. 
Bermuda grass 
(Cynodon 
dactylon) 
0.6392 0.713 n.m. n.m. n.m. n.m. 
Johnson grass 
(Sorghum 
halepensis) 
0.1226 0.754 n.m. n.m. n.m. n.m. 
Weeds       
Sorrel (Rumex 
crispus) 
0.7543 0.874** 0.0768 0.9317** 
 
0.8379** 
 
0.8588** 
 
English plantain 
(Plantago 
lanceolata) 
0.0315* 0.534 0.1349 0.8977** 
 
0.9985** 
 
0.8777** 
 
Mugwort 
(Artemisia 
vulgaris) 
0.906 0.843** 0.167 0.8458** 
 
1** 0.8458** 
 
Lamb´s quarters 
(Chenopodium 
album) 
0.3163 0.97** n.m. n.m. n.m. n.m. 
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Nettle (Urtica 
dioica) 
0.3533 0.802** 0.0021* 0.8977** 
 
0.7915 
 
0.7059 
 
Ragweed 
(Ambrosia mixtum) 
0.1264 0.733 n.m. n.m. n.m. n.m. 
Parietaria 
officinalis 
0.1827 0.878** n.m. n.m. n.m. n.m. 
Salsola kali 0.4841 0.785 n.m. n.m. n.m. n.m. 
Trees    n.m.  n.m. 
Birch (Betula) 0.0324* 0.593 0.2537 1** 0.9974** 
 
0.9974** 
 
Alder (Alnus) 0.1536 0.518 n.m. n.m. n.m. n.m. 
Oak (Quercus) 0.2329 0.738 n.m. n.m. n.m. n.m. 
Cypress 
(Cupressus) 
0.207 0.84** n.m. n.m. n.m. n.m. 
Hazel (Corylus 
avellana) 
0.336 0.787 n.m. n.m. n.m. n.m. 
Elm (Ulmus 
campestris) 
0.5896 0.629 n.m. n.m. n.m. n.m. 
Beech (Fagus 
sylvatica) 
0.9005 0.865** n.m. n.m. n.m. n.m. 
Poplar (Populus) 0.4836 0.387 n.m. n.m. n.m. n.m. 
Maple (Acer 
pseudoplantanus) 
0.3326 0.632 n.m. n.m. n.m. n.m. 
Willow (Salix) 0.0042* 0.606 0.044 0.8329** 
 
0.9278** 
 
0.8977** 
 
Olive (Olea 
europaea) 
0.1288 0.83** n.m. n.m. n.m. n.m. 
Miscelanous       
Flea saliva 
(Ctenocephalides 
saliva) 
0.6655 0.412 n.m. n.m. n.m. n.m. 
Cat dander (Felis 
catus epithelium) 
0.0054* 0.123 n.m. n.m. n.m. n.m. 
Cockroach 
(Blatella 
germanica) 
0.7068 -0.245 n.m. n.m. n.m. n.m. 
 
 
Table 2: 
Interlaboratory variability and correlation  
*: significant variability (p<0,05) 
**: good correlation (r>0,8, p<0,001) 
n.m.: Allergen not measured 
Excl.: Allergen excluded: Molds were excluded form analysis of interlaboratory correlation 
in RG, since majority of measurements was RG 0. 
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4. Discussion 
 
This report describes the first systematic study of intra and interlaboratory variability among 
commercial laboratories offering the Allercept1 Fc-e receptor test. The results of the present 
study show that variability among these three laboratories of ‘‘Allercept Program Lab 
Partners’’ is not much higher than the variability within each single laboratory. This may be 
due to the fact that these laboratories are provided with the same defined allergen reagents and 
are trained in standardised performance of the test method. Although Heska developed the 
Allercept® Fc-e receptor test, we did not consider any laboratory superior to the others. In 
practice most veterinarians and laboratories will differentiate between positive and negative 
results to determine, which allergen is to be included in an allergen extract for therapeutic 
purposes. Intralaboratory variability regarding positive or negative interpretation of the test 
revealed that altogether only 3.14% of the measurements differed. In LA as well as in LC 
3.24% disagreed, in LB there were 2.66% differing results. Interlaboratory results regarding a 
positive/negative test result for the 20 allergens measured only by LA/LC differed less often 
(1.34%) than for the 15 measured by all three laboratories (9.33%). Those disagreements 
occurred noticeably more often between LB and the other two laboratories. However, there is 
no indication which of the laboratories had false positive/false negative results. Overall 
interlaboratory disparity in 525 measurements can be considered low with 4.76%. 
As there is no evidence that the level of allergen-specific IgE correlates with the severity of 
clinical disease, the decision to use individual allergens for ASIT is based on positive or 
negative test results and the clinicians’ validation of their clinical relevance. As shown in Fig. 
2, the probability to get a false positive or false negative result is highest in the OD interval of 
50–500. OD values of 647 from 2100 measurements by LA and LC lay within this critical 
range and all but 7 of the results differing either intra- or interlaboratory lay within it. In this 
range any test result should be interpreted carefully. LB considered this fact in its 
classification of RG by dividing this range into 3 grades. RG 0, 1, and 2 grade only small 
intervals of 100–150 OD units each (Table 1). Nevertheless, interpretation of the results and 
correlation with clinical history are more difficult without knowing the exact OD value. 
Comparing results within as well as between laboratories, allergens with a very high or very 
low OD value (or higher RG) less often show differing results in terms of positive versus 
negative than those closer to the cut-off value (i.e. 50–500 OD). Altogether, intralaboratory 
variability was comparable in LA and LC. As shown in Fig. 3, the probability distribution 
functions are nearly identical and dispersion factors for individual allergens are comparable 
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between the laboratories (Fig. 1). Results of LB, provided in RG, are abstracted and therefore 
inexact. They cannot be directly compared to the OD results of the other two laboratories. 
This fact complicated comparison of the three laboratories. However, in order to provide a 
blinded study design, the laboratory was not aware of participating in this study. When we 
prospectively asked laboratory B to provide us with OD instead of RG on a routine basis, they 
refused this request. Strengths of this study include the large number of tests and the blinding 
prior to analysis by all laboratories. Even though one laboratory (Heska Ag, Fribourg, 
Switzerland) was aware of the study protocol, samples were sent in batches of multiple sera 
with different owner and dog names to avoid bias. In veterinary medicine, there are no 
standardised guidelines on how to interprete data on variance of serological allergy test 
methods. There is neither a laboratory accreditation nor a quality assurance program for 
serum allergen-specific IgE testing nor are recognised standard allergen extracts for  
calibration of assays available (DeBoer and Hillier, 2001). However, the International 
Task Force for Canine Atopic Dermatitis currently is working on a voluntary quality 
assurance program (RM, Personal Communication). In human medicine the Clinical 
Laboratory Improvement Amendments (CLIA) requires all licensed medical laboratories in 
the USA performing testing for allergenspecific IgE to take part in an external interlaboratory 
proficiency survey. However accepted coefficient of variation is only established for total IgE 
and not for allergenspecific IgE (Hamilton and Adkinson, 2003; King et al., 2007). The 
comparison of allergen-specific IgE measured by different assays shows major limitations, as  
allergen preparations vary in their immunogenicity and allergic potency between 
manufacturers and batches of allergen preparations. Influencing factors are the season in  
which the raw material is collected, cross contamination, different extraction processes during 
allergen-reagent production and stability of the extract during storage (Hamilton and 
Adkinson, 2003). Another important limitation for the validation of serum allergy tests is the 
lack of an objective standard (Williams et al., 2000). Intradermal allergy testing (IDT), 
although regarded as the ‘‘nearest gold standard available’’ in clinical practice (Patterson et 
al., 2005), has the same limitations in terms of allergen standardisation. Several reports have 
shown a poor correlation between results of IDT and serological test methods (Codner and 
Lessard, 1993; Bond et al., 1994; Haemmerling and De Weck, 1998; Wassom and Grieve, 
1998; Park et al., 2000; Foster et al., 2003; Patterson et al., 2005). Therefore we did not  
compare our IDT to the serological results. One way of evaluating intralaboratory 
reproducibility could be the creation of an ‘‘ideal assay’’ using serial dilution (Williams et al., 
2000). In a study evaluating allergen-specific IgE levels in human sera this serial dilution was 
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used. Five test methods in six commercial laboratories were compared on different days. Four   
of five assays demonstrated a substandard overall performance and several times a poor 
precision and accuracy, especially for weeds and moulds (Williams et al., 2000). In a study by 
Patterson et al. (2005), using a commercial alkaline phosphatase ELISA for semi-quantitative  
detection of canine allergen-specific IgE, significant differences in duplicate serum samples 
that were stored under different conditions were reported. As serum IgE antibodies are quite 
stable (Johansson and Yman, 1988), the most likely explanation for these suboptimal results is  
an inter-day or inter-batch variance. The suboptimal results in two studies (Williams et al. 
2000; Patterson et al., 2005) using monoclonal ELISA and RAST type assays are in contrast 
to our findings for the Fc-e receptor test. In our study aliquots were shipped after the same 
storage time at -18 °C for each aliquot and were analysed on the same day, probably in the 
same batch of measurements. Therefore in fact we evaluated the intra-assay variation. The 
inter-day or inter-batch variance, another important factor of reproducibility, is not evaluated 
by our study. Plant (1994) evaluated intralaboratory reproducibility on the same day in three 
different laboratories. He found a high reproducibility for one laboratory which had shown a 
significant difference in the aforementioned study by Patterson et al. (2005). This is in 
concordance with our findings. However, reproducibility of ‘‘same-day analyses’’ of two 
other laboratories was unsatisfactory with only 76% and 57% (Plant, 1994). To assess, if there 
is an ‘‘inter-day’’ or ‘‘inter-batch’’ variance in the same test method in the same laboratory, 
requires further studies involving multiple batches of assays on different days within the same 
laboratories. However, results of the present study show that even interlaboratory variability 
among these 3 laboratories using the same test method is acceptable. As long as there is a lack 
of an external and independant quality assurance for testing of serum allergen-specific IgE, 
independant peer-reviewed studies are needed to verify reliability of test results. Three 
laboratories using the Allercept1 Fc-e receptor test demonstrated a moderate intra- and 
interlaboratory variability. This variability was most prominent and of clinical relevance with 
low OD values around the cut-off point. Although the variability of laboratories using the 
same test method was acceptable in the present study, an independent quality assurance 
programme is needed to confirm reliability of serological measurement of allergenspecific 
IgE in veterinary medicine.  
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